v3.26.1

CONDENSED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 56,374	$ 51,159
Accounts receivable, net of allowance for credit losses of $230,524 as of March 31, 2026, and $190,686 as of December 31, 2025	13,415	13,667
Inventory, net	11,883	11,620
Prepaid expenses and other current assets	1,625	1,646
Prepaid income taxes	3,125	3,111
Total current assets	86,422	81,203
Property and equipment, net	24,225	23,856
Intangible assets, net	3,286	3,384
Deferred tax asset, net	231	94
Other assets	225	239
Total assets	114,389	108,776
Current liabilities:
Accounts payable	2,182	1,820
Accrued payroll and benefits	2,066	3,218
Other accrued taxes	427	313
Warranty reserve	144	144
Deferred revenue	3,397	2,871
Accrued income taxes	3,902	1,814
Total current liabilities	12,118	10,180
Deferred revenue, non-current	3,757	3,978
Total liabilities	15,875	14,158
Stockholders’ equity:
Common stock; $0.0001 par value per share; 31,500,000 shares authorized; 12,782,837 shares issued and outstanding as of March 31, 2026, and 12,781,774 shares issued and outstanding as of December 31, 2025	1	1
Additional paid-in capital	31,020	30,386
Retained earnings	67,493	64,231
Total stockholders' equity	98,514	94,618
Total liabilities and stockholders’ equity	$ 114,389	$ 108,776

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

IRADIMED CORP 10-Q